Publications by authors named "Davis Gates"

Claim this Profile
E
Effect of Vericiguat on Total Heart Failure Events in Compensated Outpatients With HFrEF: Insights From VICTOR.
Faiez Zannad, Yogesh N V Reddy, Irina Barash, Kevin J Anstrom, Marc P Bonaca, Davis Gates

J Am Coll Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials.
Faiez Zannad, Christopher M O'Connor, Javed Butler, Ciaran J McMullan, Kevin J Anstrom, Davis Gates

Lancet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial.
Javed Butler, Ciaran J McMullan, Kevin J Anstrom, Irina Barash, Marc P Bonaca, Davis Gates

Lancet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trial.
Robert J Mentz, Javed Butler, Ciaran J McMullan, Daniel M Wojdyla, Kevin J Anstrom, Davis Gates

Eur J Heart Fail· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial.
Clara I Saldarriaga, Faiez Zannad, Ciaran J McMullan, Aiwen Xing, Davis Gates

Eur J Heart Fail· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial.
Javed Butler, Francesco Fioretti, Ciaran J McMullan, Kevin J Anstrom, Irina Barash, Davis Gates

Eur Heart J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study.
James Welker, Juan D Pulido, Andrew T Catanzaro, Carlos D Malvestutto, Zihai Li, Davis Gates

Lancet Infect Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia.
Ignacio Martin-Loeches, Jean-François Timsit, Marin H Kollef, Richard G Wunderink, Nobuaki Shime, Davis Gates

J Antimicrob Chemother· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone Monotherapy.
Cindy L J Weinstein, Nicholas Ryan, Xiaoli Zhang, Tulin Shekar, Davis Gates

J Allergy Clin Immunol Pract· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3 study evaluating the safety and efficacy of a pediatric dose of mometasone furoate with and without formoterol for persistent asthma.
Cindy L J Weinstein, Davis Gates, Xiaoli Zhang, Tracey Varnell, Wilson Mok

Pediatr Pulmonol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia.
Antonio C Arrieta, Lillian Sung, John S Bradley, C Michel Zwaan, Davis Gates

PLoS One· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of mometasone furoate nasal spray on moderate-to-severe nasal congestion in seasonal allergic rhinitis: A responder analysis.
Eduardo Urdaneta, Kaan Tunceli, Davis Gates

Allergy Asthma Proc· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate.
Cindy L J Weinstein, Nicholas Ryan, Tulin Shekar, Davis Gates, Stephen J Lane

J Allergy Clin Immunol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoarthritis patients with pain improvement are highly likely to also have improved quality of life and functioning. A post hoc analysis of a clinical trial.
Paul M Peloso, R Andrew Moore, Wen-Jer Chen, Hsiao-Yi Lin, Davis F Gates

Scand J Pain· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial.
Robert Boostanfar, Davis Gates, Yanfen Guan, Keith Gordon, Christine McCrary Sisk

Fertil Steril· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol.
Georg Griesinger, Pierre J M Verweij, Davis Gates, Paul Devroey, Keith Gordon

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysis.
Georg Griesinger, Robert Boostanfar, Keith Gordon, Davis Gates, Christine McCrary Sisk

Reprod Biomed Online· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intercycle variability of the ovarian response in patients undergoing repeated stimulation with corifollitropin alfa in a gonadotropin-releasing hormone antagonist protocol.
Luk Rombauts, Cornelis B Lambalk, Askan Schultze-Mosgau, Jacqueline van Kuijk, Pierre Verweij, Davis Gates

Fertil Steril· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma.
Jorge Maspero, Ivan Cherrez, Dennis E Doherty, Donald P Tashkin, Piotr Kuna, Davis Gates

Respir Med· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma.
Hendrik Nolte, Ian Pavord, Vibeke Backer, Sheldon Spector, Tulin Shekar, Davis Gates

Respir Med· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relieving nasal congestion in children with seasonal and perennial allergic rhinitis: efficacy and safety studies of mometasone furoate nasal spray.
Eli O Meltzer, Carlos E Baena-Cagnani, Davis Gates, Ariel Teper

World Allergy Organ J· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The asthma disease activity score: a discriminating, responsive measure predicts future asthma attacks.
Steven Greenberg, Nancy Liu, Amarjot Kaur, Mani Lakshminarayanan, Yijie Zhou, Davis F Gates

J Allergy Clin Immunol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials.
Donald P Tashkin, Dennis E Doherty, Edward Kerwin, Carlos E Matiz-Bueno, Barbara Knorr, Davis Gates

Int J Chron Obstruct Pulmon Dis· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of intranasal mometasone furoate on itchy ear and palate in patients with seasonal allergic rhinitis.
David I Bernstein, Ariel Teper, Gokul Gopalan, Davis Gates

Ann Allergy Asthma Immunol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mometasone furoate nasal spray increases the number of minimal-symptom days in patients with acute rhinosinusitis.
Eli O Meltzer, Davis Gates, Claus Bachert

Ann Allergy Asthma Immunol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis